Characterization of CD56bright NK cells in Daclizumab HYP-treated RRMS patients

被引：0
|
作者：
Huss, David J. [1 ]
Fragoso, Maria F. [1 ]
Cullen, Patrick [2 ]
Allaire, Norm [2 ]
Fontenot, Jason D. [1 ]
机构：
[1] Biogen Idec Inc, Immunol Res, Cambridge, MA USA
[2] Biogen Idec Inc, Genet & Genom, Cambridge, MA USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.230
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
213
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [31] Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population
    Marquardt, Nicole
    Wilk, Esther
    Pokoyski, Claudia
    Schmidt, Reinhold E.
    Jacobs, Roland
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (05) : 1428 - 1439
  • [32] CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
    Elkins, J.
    Sheridan, J.
    Amaravadi, L.
    Riester, K.
    Selmaj, K.
    Bielekova, B.
    Parr, E.
    Giovannoni, G.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2015, 2 (02): : e65
  • [33] Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
    Khan, Md Abdullah Al Kamran
    Sedgwick, Alexander James
    Sun, Yuhan
    Vivian, Julian P.
    Corbett, Alexandra J.
    Dolcetti, Riccardo
    Mantamadiotis, Theo
    Mangiola, Stefano
    Barrow, Alexander David
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [34] THE CD56BRIGHT SUBSET OF NK CELLS IS GREATLY EXPANDED IN INFLAMMATORY SYNOVIAL FLUID AND TISSUE
    Dalbeth, N.
    Callan, M.
    RHEUMATOLOGY, 2003, 42 : 126 - 126
  • [35] Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis Patients
    Johnson, Trina A.
    Evans, Barbara L.
    Durafourt, Bryce A.
    Blain, Manon
    Lapierre, Yves
    Bar-Or, Amit
    Antel, Jack P.
    JOURNAL OF IMMUNOLOGY, 2011, 187 (01): : 570 - 579
  • [36] CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells
    Vukicevic, Marija
    Chalandon, Yves
    Helg, Claudine
    Matthes, Thomas
    Dantin, Carole
    Huard, Bertrand
    Chizzolini, Carlo
    Passweg, Jakob
    Roosnek, Eddy
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (11) : 3246 - 3254
  • [37] NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma
    Seymour, Frances
    Cavenagh, Jamie D.
    Mathews, Janet
    Gribben, John G.
    BLOOD ADVANCES, 2022, 6 (17) : 5152 - 5159
  • [38] The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death
    Thoren, Fredrik B.
    Romero, Ana I.
    Hermodsson, Svante
    Hellstrand, Kristoffer
    JOURNAL OF IMMUNOLOGY, 2007, 179 (02): : 781 - 785
  • [39] Cutaneous events in daclizumab HYP-treated patients did not impact patient-reported outcomes in the DECIDE study
    Liu, Y.
    Garland, R.
    Yeh, W-S
    Wang, P.
    Ting, J.
    Ye, X.
    Wakeford, C.
    Sabatella, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 283 - 283
  • [40] Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients
    Jiang, Yujie
    Qin, Shuang
    Wei, Xin
    Liu, Xiaoyuan
    Guan, Jingjing
    Zhu, Hengyue
    Chang, Guolin
    Chen, Yingxiao
    Lu, Hong
    Qian, Jingjing
    Wang, Zhongyong
    Shen, Mo
    Lin, Xiangyang
    IMMUNOLOGY LETTERS, 2021, 232 : 9 - 19
12345